ClinicalTrials.gov
ClinicalTrials.gov Menu

Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00574132
Recruitment Status : Completed
First Posted : December 17, 2007
Last Update Posted : November 25, 2013
Sponsor:
Collaborator:
Pfizer
Information provided by (Responsible Party):
JANSSEN Alzheimer Immunotherapy Research & Development, LLC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2012
  Actual Study Completion Date : June 2012
  Certification/Extension First Submitted : September 27, 2013
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):